$100,000,000
BARDA OTHER TRANSACTION PRIZE VEHICLE
Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.
What the model surfaced from this award
Latest obligation on a 2023 BARDA prize vehicle funding biotech innovation for pandemic preparedness and medical countermeasures.
BARDA's other-transaction authority accelerates high-risk biotech R&D outside traditional procurement; this $100M increment signals sustained federal investment in rapid-response medical countermeasure development.
Luminary Labs' work likely involves manufacturing partnerships and clinical-trial supply chains for novel therapeutics or vaccines; this increment may expand production readiness or scale-up timelines.
U.S. biodefense and pandemic-preparedness R&D directly counters China's advances in mRNA and vaccine platforms; BARDA's prize-vehicle model aims to outpace foreign competitors in speed-to-market.
Generated by award_classification v2.1.0 via claude-haiku-4-5-20251001 on 2026-05-28. Cost: $0.003216.
- USAspending.gov — all awards for this UEI →
- SAM.gov entity registration →
- Award record ingested from usaspending. Source identifier CONT_AWD_75A50123C00059_7505_-NONE-_-NONE-.
The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.